At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Princeton researchers awarded NJ ACTS grant to study dendritic plasticity in neuropsychiatric disorders.
- Exercise Improves Brain Function, Possibly Reducing Dementia Risk.
- Join NJ ACTS Biostatistics and Epidemiology for their Workshop Series on 2/20 at 12pm
- Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity.
- New NJACTS Publication
Categories
- Community (2,127)
- Covid (981)
- CTO Events (6)
- News (2,712)
- Pilots (21)